Hubbard VG, Friedmann AC, Goldsmith P, et al.
The British journal of dermatology. Date of publication 2005 May 1;volume 152(5):1059-61.
1. Br J Dermatol. 2005 May;152(5):1059-61.
Systemic pyoderma gangrenosum responding to infliximab and adalimumab.
Hubbard VG(1), Friedmann AC, Goldsmith P.
Author information:
(1)Department of Dermatology, Royal London Hospital, Whitechapel Road, London E1
1BB, UK. vghubbard@yahoo.co.uk
Pyoderma gangrenosum (PG) is frequently associated with constitutional symptoms
as part of a nonspecific inflammatory response. However, extracutaneous discrete
aseptic neutrophilic infiltrates are extremely rare. We report a patient with
idiopathic PG with splenic and psoas muscle involvement. His disease was
extremely aggressive and was unresponsive to conventional immunosuppressive
therapy. His cutaneous and extracutaneous PG cleared with infliximab and
adalimumab.
DOI: 10.1111/j.1365-2133.2005.06467.x
PMID: 15888172 [Indexed for MEDLINE]
Appears in following Topics:
